CoChat

The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy

Open access
Jacques, Adam M., Briceno, Natalia, Messer, Andrew E., Gallon, Clare E., Jalilzadeh, Shapour, Garcia, Edwin, Kikonda-Kanda, Gaelle, Goddard, Jennifer, Harding, Sian E., Watkins, Hugh, Esteban, M. Tomé, Tsang, Victor T., McKenna, William J., Marston, Steven B. · 2008 · Cardiovascular Research

The DOI matches its Crossref record; 39 of the 40 references it cites were found in a registry or an index, and 1 are not checked yet.

Abstract

AIM: The aim of the study was to compare the functional and structural properties of the motor protein, myosin, and isolated myocyte contractility in heart muscle excised from hypertrophic cardiomyopathy patients by surgical myectomy with explanted failing heart and non-failing donor heart muscle. METHODS: Myosin was isolated and studied using an in vitro motility assay. The distribution of myosin light chain-1 isoforms was measured by two-dimensional electrophoresis. Myosin light chain-2 phosphorylation was measured by sodium dodecyl sulphate-polyacrylamide gel electrophoresis using Pro-Q Diamond phosphoprotein stain. RESULTS: The fraction of actin filaments moving when powered by myectomy myosin was 21% less than with donor myosin (P = 0.006), whereas the sliding speed was not different (0.310 +/- 0.034 for myectomy myosin vs. 0.305 +/- 0.019 microm/s for donor myosin in six paired experiments). Failing heart myosin showed 18% reduced motility. One myectomy myosin sample produced a consistently higher sliding speed than donor heart myosin and was identified with a disease-causing heavy chain mutation (V606M). In myectomy myosin, the level of atrial light chain-1 relative to ventricular light chain-1 was 20 +/- 5% compared with 11 +/- 5% in donor heart myosin and the level of myosin light chain-2 phosphorylation was decreased by 30-45%. Isolated cardiomyocytes showed reduced contraction amplitude (1.61 +/- 0.25 vs. 3.58 +/- 0.40%) and reduced relaxation rates compared with donor myocytes (TT(50%) = 0.32 +/- 0.09 vs. 0.17 +/- 0.02 s). CONCLUSION: Contractility in myectomy samples resembles the hypocontractile phenotype found in end-stage failing heart muscle irrespective of the primary stimulus, and this phenotype is not a direct effect of the hypertrophy-inducing mutation. The presence of a myosin heavy chain mutation causing hypertrophic cardiomyopathy can be predicted from a simple functional assay.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cvr/cvn094

Cites

39 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Contraction of isolated myocytes from myectomy muscle. (A) Two ventricular myocytes from myectomy samples, showing branched appearance, compared with the more usual rod-shaped appearance of a ventricular myocyte from failing heart. (B) Contraction amplitude (% shortening) and time-to-50% relaxation of ventricular myocytes from myectomy (21 myocytes/10 hearts) and failing (41 myocytes/16 hearts) samples. #P < 0.001, variances significantly different; ***P < 0.001, means significantly different.
Figure 1 Contraction of isolated myocytes from myectomy muscle. (A) Two ventricular myocytes from myectomy samples, showing branched appearance, compared with the more usual rod-shaped appearance of a ventricular myocyte from failing heart. (B) Contraction amplitude (% shortening) and time-to-50% relaxation of ventricular myocytes from myectomy (21 myocytes/10 hearts) and failing (41 myocytes/16 hearts) samples. #P < 0.001, variances significantly different; ***P < 0.001, means significantly different.CC BY-NC · PubMed Central
Figure 2 Isolation of myosin from human heart muscle. SDS–PAGE of (A) high salt extract of muscle myofibrils, (B) supernatant containing myosin and troponin–tropomyosin after ultracentrifugation, and (C) pure myosin sedimented at low salt concentration.
Figure 2 Isolation of myosin from human heart muscle. SDS–PAGE of (A) high salt extract of muscle myofibrils, (B) supernatant containing myosin and troponin–tropomyosin after ultracentrifugation, and (C) pure myosin sedimented at low salt concentration.CC BY-NC · PubMed Central
Figure 3 In vitro motility of human cardiac myosin with rabbit skeletal muscle actin. Actin filament motility was measured at 30°C in dual-chamber motility cells containing immobilized donor and myectomy or failing heart myosin pairs as indicated. (A, B) Myosin from five myectomy samples (M1, M3, M4, M5, M7, black bars) was compared with myosin from donor muscle samples (N6 or N7, grey bars) in paired assays. Movement was analysed to yield the sliding speed (A) and the fraction of filaments that were moving (B). There was no systematic difference in sliding speed (mean sliding speed myectomy myosin was 94 ± 0.07% of donor P = 0.44), but the fraction of filaments motile was always lower with myectomy myosin (mean fraction myectomy myosin motile was 79 ± 0.03% of donor, P = 0.004). (C, D) Myosin from failing heart muscle (FA, FB, FC, FD, FE, black bars) was compared with myosin from donor muscle (NA, NB, NC, ND, NE, grey bars) in paired assays. Movement was analysed to yield the sliding speed (C) and the fraction of filaments that were moving (D). Sliding speed was slightly reduced in failing heart myosin (mean sliding speed failing myosin was 89 ± 0.03% of donor, P = 0.004) and the fraction of filaments motile was also lower (mean fraction failing myosin motile was 82 ± 0.04% of donor, P = 0.026).
Figure 3 In vitro motility of human cardiac myosin with rabbit skeletal muscle actin. Actin filament motility was measured at 30°C in dual-chamber motility cells containing immobilized donor and myectomy or failing heart myosin pairs as indicated. (A, B) Myosin from five myectomy samples (M1, M3, M4, M5, M7, black bars) was compared with myosin from donor muscle samples (N6 or N7, grey bars) in paired assays. Movement was analysed to yield the sliding speed (A) and the fraction of filaments that were moving (B). There was no systematic difference in sliding speed (mean sliding speed myectomy myosin was 94 ± 0.07% of donor P = 0.44), but the fraction of filaments motile was always lower with myectomy myosin (mean fraction myectomy myosin motile was 79 ± 0.03% of donor, P = 0.004). (C, D) Myosin from failing heart muscle (FA, FB, FC, FD, FE, black bars) was compared with myosin from donor muscle (NA, NB, NC, ND, NE, grey bars) in paired assays. Movement was analysed to yield the sliding speed (C) and the fraction of filaments that were moving (D). Sliding speed was slightly reduced in failing heart myosin (mean sliding speed failing myosin was 89 ± 0.03% of donor, P = 0.004) and the fraction of filaments motile was also lower (mean fraction failing myosin motile was 82 ± 0.04% of donor, P = 0.026).CC BY-NC · PubMed Central
Figure 4 Ca2+ regulation of motility of reconstituted thin filaments. Thin filaments were reconstituted with 10 nmol/L TRITC-phalloidin-actin, 50 nmol/L human cardiac tropomyosin, and 40 nmol/L human cardiac troponin. In vitro motility of reconstituted thin filaments was measured at pCa5 (black bars) and pCa9 (grey bars) in dual-chamber cells and the fraction of filaments motile is plotted. Ca2+ regulation of motility was measured with myosin from two donor (N) heart and five myectomy (M) muscle samples. Only M5 showed abnormal regulation.
Figure 4 Ca2+ regulation of motility of reconstituted thin filaments. Thin filaments were reconstituted with 10 nmol/L TRITC-phalloidin-actin, 50 nmol/L human cardiac tropomyosin, and 40 nmol/L human cardiac troponin. In vitro motility of reconstituted thin filaments was measured at pCa5 (black bars) and pCa9 (grey bars) in dual-chamber cells and the fraction of filaments motile is plotted. Ca2+ regulation of motility was measured with myosin from two donor (N) heart and five myectomy (M) muscle samples. Only M5 showed abnormal regulation.CC BY-NC · PubMed Central
Figure 5 Myosin light chain detection by two-dimensional electrophoresis. Thirty micrograms of myofibrils were separated by 2D electrophoresis and stained with SYPRO Ruby. The region of the gels showing VLC-1, ALC-1, and MLC-2 are shown. VLC-1 (MYL3-HUMAN) has a pI of 5.03 and Mr of 21 800 Da, ALC-1 (MYL4-HUMAN) has a pI of 4.98 and Mr of 21 433 Da. ALC-1 was identified in a sample of mouse heart atrium located above and to the left of VLC-1 and was found to be present in all samples tested but more prominent in the myectomy samples (arrow). Densitometry of ALC-1 and VLC-1 spots was performed manually and the ratio of the two isoforms is plotted on the left. Values were quite variable with a trend towards higher ALC-1 content in the myectomy samples.
Figure 5 Myosin light chain detection by two-dimensional electrophoresis. Thirty micrograms of myofibrils were separated by 2D electrophoresis and stained with SYPRO Ruby. The region of the gels showing VLC-1, ALC-1, and MLC-2 are shown. VLC-1 (MYL3-HUMAN) has a pI of 5.03 and Mr of 21 800 Da, ALC-1 (MYL4-HUMAN) has a pI of 4.98 and Mr of 21 433 Da. ALC-1 was identified in a sample of mouse heart atrium located above and to the left of VLC-1 and was found to be present in all samples tested but more prominent in the myectomy samples (arrow). Densitometry of ALC-1 and VLC-1 spots was performed manually and the ratio of the two isoforms is plotted on the left. Values were quite variable with a trend towards higher ALC-1 content in the myectomy samples.CC BY-NC · PubMed Central
Figure 6 Phosphorylation of human cardiac muscle myofibrils. (A) SDS–PAGE of 10 µg myofibrils extracted from donor and myectomy muscle samples, successively stained with Pro-Q Diamond to label phosphoproteins and SYPRO Ruby total protein stain. High levels of phosphorylation are detected in MyBP-C, troponin T, troponin I, and MLC-2. (B) The level of MLC-2 phosphorylation is expressed as the ratio of Pro-Q Diamond band volume:SYPRO Ruby band volume for 12 measurements from 6 donor samples and 15 measurements from 8 myectomy samples. The mean ratios are 0.78 ± 0.06 for donor and 0.44 ± 0.03 for myectomy samples (P < 0.0001).
Figure 6 Phosphorylation of human cardiac muscle myofibrils. (A) SDS–PAGE of 10 µg myofibrils extracted from donor and myectomy muscle samples, successively stained with Pro-Q Diamond to label phosphoproteins and SYPRO Ruby total protein stain. High levels of phosphorylation are detected in MyBP-C, troponin T, troponin I, and MLC-2. (B) The level of MLC-2 phosphorylation is expressed as the ratio of Pro-Q Diamond band volume:SYPRO Ruby band volume for 12 measurements from 6 donor samples and 15 measurements from 8 myectomy samples. The mean ratios are 0.78 ± 0.06 for donor and 0.44 ± 0.03 for myectomy samples (P < 0.0001).CC BY-NC · PubMed Central
Figure 7 Measurement of myosin light chain-2 phosphorylation in purified myosin. (A) SDS–PAGE of purified myosin, Coomassie Blue staining. (B) Pro-Q Diamond phosphoprotein staining of the same gel showing MLC-2 bands only. (C) Relative MLC-2 phosphorylation levels. Method as described in Figure 6. The mean Pro-Q Diamond band volume/Coomassie Blue band volume ratios (Q/C) are 0.20 ± 0.015 (n = 4) for donor and 0.14 ± 0.016 (n = 7) for myectomy samples (P = 0.029).
Figure 7 Measurement of myosin light chain-2 phosphorylation in purified myosin. (A) SDS–PAGE of purified myosin, Coomassie Blue staining. (B) Pro-Q Diamond phosphoprotein staining of the same gel showing MLC-2 bands only. (C) Relative MLC-2 phosphorylation levels. Method as described in Figure 6. The mean Pro-Q Diamond band volume/Coomassie Blue band volume ratios (Q/C) are 0.20 ± 0.015 (n = 4) for donor and 0.14 ± 0.016 (n = 7) for myectomy samples (P = 0.029).CC BY-NC · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 1

  1. Gallon, 2007, Post-translational modification of TnT, TnI, MyBP-C and MLC-2 in HOCM human heart muscle, J Muscle Res Cell Motil

Cited by

See all 43

Metadata

Authors
Jacques, A. M., Briceno, N., Messer, A. E., Gallon, C. E., Jalilzadeh, S., Garcia, E., Kikonda-Kanda, G., Goddard, J., Harding, S. E., Watkins, H., Esteban, M. T., Tsang, V. T., McKenna, W. J., & Marston, S. B.
Affiliations
  • Imperial College London (GB)
  • John Radcliffe Hospital (GB)
  • University College London (GB)
Corresponding author
Marston, Steven B.
Venue
Cardiovascular Research
Published
2008-04-14
Volume
79
Issue
3
Pages
481-491
ISSN
  • 0008-6363 (ISSN-L)
  • 1755-3245
OpenAlex
W2074688769
Cited by
43
References
40
Citations by year
2026: 1 · 2024: 1 · 2023: 1 · 2022: 1 · 2021: 1 · 2020: 3 · 2018: 2 · 2016: 1 · 2015: 4 · 2014: 4 · 2013: 4 · 2012: 3
FWCI
4.14
Type
journal article
Language
en
Open access
Licence
other-oa
Locations
  • Cardiovascular Research (publishedVersion, other-oa)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • St George's Online Research Archive (St George's University of London) (acceptedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Funders
  • National Institute for Health and Care Research
  • British Heart Foundation (RG/07/012/24110)
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
Keywords
hypertrophic obstructive cardiomyopathy, cardiac myosin, myosin light chain 2 phosphorylation, cardiomyocyte contractility, myectomy, heart failure, myosin motility, molecular phenotypes
MeSH terms
Adult, Cardiomyopathy, Hypertrophic, Genotype, Heart Failure, Humans, Actin Cytoskeleton, Middle Aged, Muscle Contraction, Mutation, Phenotype, Phosphorylation, Myosin Light Chains, Myosin Heavy Chains, Cardiac Myosins, Myocytes, Cardiac, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy. https://app.cochat.ai/papers/10.1093/cvr/cvn094
The paper
Jacques, A. M., Briceno, N., Messer, A. E., Gallon, C. E., Jalilzadeh, S., Garcia, E., Kikonda-Kanda, G., Goddard, J., Harding, S. E., Watkins, H., Esteban, M. T., Tsang, V. T., McKenna, W. J., & Marston, S. B. (2008). The molecular phenotype of human cardiac myosin associated with hypertrophic obstructive cardiomyopathy. Cardiovascular Research. https://doi.org/10.1093/cvr/cvn094

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.